BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Effinger A, O'driscoll CM, Mcallister M, Fotaki N. Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review. Journal of Pharmacy and Pharmacology 2019;71:674-98. [DOI: 10.1111/jphp.12928] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Thanou M, Vllasaliu D. Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease. Eur J Pharm Biopharm 2020;155:128-38. [PMID: 32853696 DOI: 10.1016/j.ejpb.2020.08.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Govender R, Abrahmsén-Alami S, Folestad S, Olsson M, Larsson A. Enabling modular dosage form concepts for individualized multidrug therapy: Expanding the design window for poorly water-soluble drugs. Int J Pharm 2021;602:120625. [PMID: 33892062 DOI: 10.1016/j.ijpharm.2021.120625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Vinarov Z, Abrahamsson B, Artursson P, Batchelor H, Berben P, Bernkop-Schnürch A, Butler J, Ceulemans J, Davies N, Dupont D, Flaten GE, Fotaki N, Griffin BT, Jannin V, Keemink J, Kesisoglou F, Koziolek M, Kuentz M, Mackie A, Meléndez-Martínez AJ, McAllister M, Müllertz A, O'Driscoll CM, Parrott N, Paszkowska J, Pavek P, Porter CJH, Reppas C, Stillhart C, Sugano K, Toader E, Valentová K, Vertzoni M, De Wildt SN, Wilson CG, Augustijns P. Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network. Adv Drug Deliv Rev 2021;171:289-331. [PMID: 33610694 DOI: 10.1016/j.addr.2021.02.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 30.0] [Reference Citation Analysis]
4 da Silva Ferreira AR, Märtson AG, de Boer A, Wardill HR, Alffenaar JW, Harmsen HJM, Tissing WJE. Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs? Biomedicines 2021;9:1389. [PMID: 34680506 DOI: 10.3390/biomedicines9101389] [Reference Citation Analysis]
5 Hens B, Gonzalez-alvarez I, Bermejo M. Exploring the Predictive Power of the In Situ Perfusion Technique towards Drug Absorption: Theory, Practice, and Applications. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.1c00861] [Reference Citation Analysis]
6 Sharma S, Prasad B. Meta-Analysis of Food Effect on Oral Absorption of Efflux Transporter Substrate Drugs: Does Delayed Gastric Emptying Influence Drug Transport Kinetics? Pharmaceutics 2021;13:1035. [PMID: 34371727 DOI: 10.3390/pharmaceutics13071035] [Reference Citation Analysis]
7 Effinger A, M O'Driscoll C, McAllister M, Fotaki N. Gastrointestinal diseases and their impact on drug solubility: Ulcerative Colitis. Eur J Pharm Sci 2020;152:105458. [PMID: 32645424 DOI: 10.1016/j.ejps.2020.105458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 García MA, Varum F, Al-Gousous J, Hofmann M, Page S, Langguth P. In Vitro Methodologies for Evaluating Colon-Targeted Pharmaceutical Products and Industry Perspectives for Their Applications. Pharmaceutics 2022;14:291. [PMID: 35214024 DOI: 10.3390/pharmaceutics14020291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Jereb R, Opara J, Bajc A, Petek B. Evaluating the Impact of Physiological Properties of the Gastrointestinal Tract On Drug In Vivo Performance Using Physiologically Based Biopharmaceutics Modeling and Virtual Clinical Trials. J Pharm Sci 2021;110:3069-81. [PMID: 33878322 DOI: 10.1016/j.xphs.2021.04.007] [Reference Citation Analysis]
10 Barducci L, Norton JC, Sarker S, Mohammed S, Jones R, Valdastri P, Terry BS. Fundamentals of the gut for capsule engineers. Prog Biomed Eng 2020;2:042002. [DOI: 10.1088/2516-1091/abab4c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
11 Hatton GB, Madla CM, Rabbie SC, Basit AW. Gut reaction: impact of systemic diseases on gastrointestinal physiology and drug absorption. Drug Discov Today 2019;24:417-27. [PMID: 30453059 DOI: 10.1016/j.drudis.2018.11.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
12 Omonga N, Zia Z, Ghanbour H, Ragazzon-smith A, Foster H, Hadfield J, Ragazzon P. Facile synthesis and biological evaluation of chrysin derivatives. Journal of Chemical Research 2021;45:1083-92. [DOI: 10.1177/17475198211057467] [Reference Citation Analysis]
13 Effinger A, O'Driscoll CM, McAllister M, Fotaki N. Gastrointestinal diseases and their impact on drug solubility: Crohn's disease. Eur J Pharm Sci 2020;152:105459. [PMID: 32649984 DOI: 10.1016/j.ejps.2020.105459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Loisios-Konstantinidis I, Dressman J. Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of In Vivo Clinical Studies: Current Status, Challenges, and Opportunities. Mol Pharm 2021;18:1-17. [PMID: 33320002 DOI: 10.1021/acs.molpharmaceut.0c00903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kim T, de Oliveira Silva Lautenschlager S, Ma Q, Eller K, Pollheimer MJ, Lazarin-Bidóia D, Nakamura CV, Anders HJ, Steiger S. Drug Crystal-Related Gastrointestinal Complications Involve Crystal-Induced Release of Neutrophil and Monocyte Extracellular Traps. Cells 2020;9:E2481. [PMID: 33203124 DOI: 10.3390/cells9112481] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Liu CS, Liang X, Wei XH, Chen FL, Tang QF, Tan XM. Comparative metabolism of the eight main bioactive ingredients of gegen qinlian decoction by the intestinal flora of diarrhoeal and healthy piglets. Biomed Chromatogr. 2019;33:e4421. [PMID: 30362136 DOI: 10.1002/bmc.4421] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
17 Han J, Ye T, Liu YH, Chen X, Miao GP. Effects of food matrix and probiotics on the bioavailability of curcumin in different nanoformulations. J Sci Food Agric 2021;101:5627-35. [PMID: 33713049 DOI: 10.1002/jsfa.11215] [Reference Citation Analysis]
18 Fagerberg JH, Zarmpi P, Jabbar H, Fotaki N. Affinity of Lipophilic Drugs to Mixed Lipid Aggregates in Simulated Gastrointestinal Fluids. J Pharm Sci 2021;110:186-97. [PMID: 33065126 DOI: 10.1016/j.xphs.2020.09.053] [Reference Citation Analysis]
19 Wen HN, Liu YX, Xu D, Zhao KJ, Jiao Z. Population pharmacokinetic modeling of pyrotinib in patients with HER2-positive advanced or metastatic breast cancer. Eur J Pharm Sci 2021;159:105729. [PMID: 33484815 DOI: 10.1016/j.ejps.2021.105729] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Stillhart C, Vučićević K, Augustijns P, Basit AW, Batchelor H, Flanagan TR, Gesquiere I, Greupink R, Keszthelyi D, Koskinen M, Madla CM, Matthys C, Miljuš G, Mooij MG, Parrott N, Ungell A, de Wildt SN, Orlu M, Klein S, Müllertz A. Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review. European Journal of Pharmaceutical Sciences 2020;147:105280. [DOI: 10.1016/j.ejps.2020.105280] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
21 Vyhlidal CA, Chapron BD, Ahmed A, Singh V, Casini R, Shakhnovich V. Effect of Crohn's Disease on Villous Length and CYP3A4 Expression in the Pediatric Small Intestine. Clin Transl Sci 2021;14:729-36. [PMID: 33278326 DOI: 10.1111/cts.12938] [Reference Citation Analysis]
22 Quade BN, Parker MD, Occhipinti R. The therapeutic importance of acid-base balance. Biochem Pharmacol 2021;183:114278. [PMID: 33039418 DOI: 10.1016/j.bcp.2020.114278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Govender R, Abrahmsén-Alami S, Larsson A, Borde A, Liljeblad A, Folestad S. Independent Tailoring of Dose and Drug Release via a Modularized Product Design Concept for Mass Customization. Pharmaceutics 2020;12:E771. [PMID: 32823877 DOI: 10.3390/pharmaceutics12080771] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
24 Zhao P, Xia X, Xu X, Leung KKC, Rai A, Deng Y, Yang B, Lai H, Peng X, Shi P, Zhang H, Chiu PWY, Bian L. Nanoparticle-assembled bioadhesive coacervate coating with prolonged gastrointestinal retention for inflammatory bowel disease therapy. Nat Commun 2021;12:7162. [PMID: 34887414 DOI: 10.1038/s41467-021-27463-6] [Reference Citation Analysis]
25 Effinger A, McAllister M, Tomaszewska I, O'Driscoll CM, Taylor M, Gomersall S, Heaton J, Smith KL, Sarcevica I, Young SL, Fotaki N. Investigating the Impact of Crohn's Disease on the Bioaccessibility of a Lipid-Based Formulation with an In Vitro Dynamic Gastrointestinal Model. Mol Pharm 2021;18:1530-43. [PMID: 33656882 DOI: 10.1021/acs.molpharmaceut.0c00807] [Reference Citation Analysis]
26 Stamatopoulos K, Karandikar S, Goldstein M, O'Farrell C, Marciani L, Sulaiman S, Hoad CL, Simmons MJH, Batchelor HK. Dynamic Colon Model (DCM): A Cine-MRI Informed Biorelevant In Vitro Model of the Human Proximal Large Intestine Characterized by Positron Imaging Techniques. Pharmaceutics 2020;12:E659. [PMID: 32668624 DOI: 10.3390/pharmaceutics12070659] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
27 Jacobson ER, Stacy NI, Mader DR, Moretti R, Zirkelbach B, Carlile O, O'Connor CD, Caperton KJ, Maxwell LK. Pharmacokinetics of ponazuril after administration of a single oral dose to green turtles (Chelonia mydas). Vet Q 2021;41:323-31. [PMID: 34789079 DOI: 10.1080/01652176.2021.2008045] [Reference Citation Analysis]
28 Effinger A, O'Driscoll CM, McAllister M, Fotaki N. Predicting budesonide performance in healthy subjects and patients with Crohn's disease using biorelevant in vitro dissolution testing and PBPK modeling. Eur J Pharm Sci 2021;157:105617. [PMID: 33164838 DOI: 10.1016/j.ejps.2020.105617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]